# KP Pharmaceutical Technology - Inspection Records

Source: https://www.globalkeysolutions.net/companies/kp-pharmaceutical-technology/acd7d203-2bd2-4702-a902-83c45f57890f

> Inspection records and compliance data for KP Pharmaceutical Technology in Bloomington, Indiana. Access full analysis and detailed observations.

---

## Details

- Name: KP Pharmaceutical Technology
- FEI Number: 3001802820
- City: Bloomington
- State: Indiana
- Country Name: United States
- Address Line 1: 1212 W Rappel Ave
- Zip Code: 47404
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1307874 - KP Pharmaceutical Technology - 2026-02-13](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/86f3f41c-36c0-4599-8c5f-bf64f6e61ae2) — source: FDA, date: February 13, 2026
- [FDA Inspection 1307874 - KP Pharmaceutical Technology - 2026-02-13](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/3a40462d-c790-4da4-b4ca-e999e2677bba) — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2026
- [483 - KP Pharmaceutical Technology - 2024-03-21](https://www.globalkeysolutions.net/records/483/kp-pharmaceutical-technology/c774dd17-c5c5-4769-9d75-e5911bfefd41) — source: FDA, date: March 21, 2024
- [FDA Inspection 1234088 - KP Pharmaceutical Technology - 2024-03-21](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/9de68d27-53a1-437c-bd52-951561889b31) — classification: Official Action Indicated (OAI), source: FDA, date: March 21, 2024
- [483 - KP Pharmaceutical Technology - 2024-03-11](https://www.globalkeysolutions.net/records/483/kp-pharmaceutical-technology/173fdef4-ac0a-4d24-b45a-3209f2cd0614) — source: FDA, date: March 11, 2024
- [483 - KP Pharmaceutical Technology - 2023-02-03](https://www.globalkeysolutions.net/records/483/kp-pharmaceutical-technology/af93ffc6-90c2-4cba-8eba-f8fa21b7a395) — source: FDA, date: February 3, 2023
- [FDA Inspection 1196557 - KP Pharmaceutical Technology - 2023-02-03](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/5548ae02-ff10-4eff-8460-ac8c20cfecd8) — classification: Official Action Indicated (OAI), source: FDA, date: February 3, 2023
- [FDA Inspection 1031466 - KP Pharmaceutical Technology - 2017-11-09](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/2d1a2289-0de3-49b4-b147-3a4a11798cc4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2017
- [FDA Inspection 940349 - KP Pharmaceutical Technology - 2015-05-21](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/07e6f536-5088-4142-806b-c7ca89668d42) — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2015
- [FDA Inspection 814448 - KP Pharmaceutical Technology - 2012-12-17](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/4b9f3e27-c95e-49d0-8bdd-30a550539a53) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 17, 2012
- [FDA Inspection 709700 - KP Pharmaceutical Technology - 2011-01-25](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/35e31041-b581-4681-b162-301add4bfa76) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2011
- [FDA Inspection 614758 - KP Pharmaceutical Technology - 2009-09-22](https://www.globalkeysolutions.net/records/fda_inspections/kp-pharmaceutical-technology/257bf160-00e3-48de-9e1b-e07d1f9ac39c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2009

## Related Companies

- [Sciegen Pharmaceuticals Inc](https://www.globalkeysolutions.net/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d)
- [Patheon Puerto Rico, Inc.](https://www.globalkeysolutions.net/companies/patheon-puerto-rico-inc/e9addf1c-234e-45b2-a136-75152851936b)
- [Sanofi S.r.l.](https://www.globalkeysolutions.net/companies/sanofi-srl/54ba861a-36eb-4486-a4ba-2a8194cdf7a5)
- [Unichem Laboratories Limited](https://www.globalkeysolutions.net/companies/unichem-laboratories-limited/2b8c7905-52a2-4b2e-a97e-0a1d5b2d88ea)
- [Recipharm Pharmaservices Private Limited](https://www.globalkeysolutions.net/companies/recipharm-pharmaservices-private-limited/cb3eebaa-2270-4301-a4a2-3ce95d076cd6)
- [TEVA Pharmaceuticals USA, Inc.](https://www.globalkeysolutions.net/companies/teva-pharmaceuticals-usa-inc/80ca25b0-727b-44e6-aedf-39bf4f30ef14)
- [Micro Labs Limited](https://www.globalkeysolutions.net/companies/micro-labs-limited/31ef3982-06b8-43c1-8e7e-585fb2dd02e7)
- [Macleods Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/macleods-pharmaceuticals-limited/cd51cd03-2afe-4dcd-93b4-20beee9d0521)
- [C.P.M. Contract Pharma GmbH & Co. KG](https://www.globalkeysolutions.net/companies/cpm-contract-pharma-gmbh-co-kg/603d56c1-f951-4a2d-9098-cd2fc6ee54f6)
- [United Therapeutics Corporation](https://www.globalkeysolutions.net/companies/united-therapeutics-corporation/5f83ecf2-e9e1-408a-9a1b-b381eac864a1)

## Related Officers

- [Investigator ](https://www.globalkeysolutions.net/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Investigator](https://www.globalkeysolutions.net/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)
- [President and CEO](https://www.globalkeysolutions.net/people/rajinder-p-mathura/06f10169-a154-46c8-98fb-89864ef07127)
- [Travis V. Hull](https://www.globalkeysolutions.net/people/travis-v-hull/1f3b5843-29ed-4291-8a8a-a2bf3ac36988)
- [Investigator?](https://www.globalkeysolutions.net/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)